These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1724602)

  • 1. Changes in CSF neurotransmitters in infantile spasms.
    Langlais PJ; Wardlow ML; Yamamoto H
    Pediatr Neurol; 1991; 7(6):440-5. PubMed ID: 1724602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in CSF tryptophan metabolite levels in infantile spasms].
    Yamamoto H; Egawa B; Horiguchi K; Kaku A; Yamada K
    No To Hattatsu; 1992 Nov; 24(6):530-5. PubMed ID: 1419165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on CSF tryptophan metabolism in infantile spasms.
    Yamamoto H
    Pediatr Neurol; 1991; 7(6):411-4. PubMed ID: 1724601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment.
    Airaksinen E; Tuomisto L; Riikonen R
    Brain Dev; 1992 Nov; 14(6):386-90. PubMed ID: 1283505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms.
    Silverstein F; Johnston MV
    Neurology; 1984 Jan; 34(1):102-5. PubMed ID: 6197678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative neurotransmitter abnormalities in infantile spasms: cerebrospinal fluid neurochemistry and drug effects.
    Pranzatelli MR
    J Child Neurol; 1994 Apr; 9(2):119-29. PubMed ID: 7911815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites.
    Takeuchi Y; Tominaga M; Mitsufuji N; Yamazoe I; Kawase S; Nishimura A; Matsuo S; Sawada T
    Pediatr Neurol; 1995 Feb; 12(2):139-45. PubMed ID: 7540012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms.
    Yamamoto H; Shindo I; Egawa B; Horiguchi K
    Pediatr Neurol; 1994 Feb; 10(1):9-12. PubMed ID: 8198681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated homovanillic acid in cerebrospinal fluid of children with infantile spasms.
    Ito M; Okuno T; Mikawa H; Osumi Y
    Epilepsia; 1980 Aug; 21(4):387-92. PubMed ID: 6156822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid GABA levels in children with infantile spasms.
    Ito M; Mikawa H; Taniguchi T
    Neurology; 1984 Feb; 34(2):235-8. PubMed ID: 6320056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocarnosine levels in cerebrospinal fluid of patients with infantile spasms under ACTH therapy.
    Ohtsuka C; Sato Y; Takahashi H
    Brain Dev; 1983; 5(5):464-8. PubMed ID: 6318586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF; Mohs RC; Davis KL
    Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid corticotropin and cortisol are reduced in infantile spasms.
    Baram TZ; Mitchell WG; Hanson RA; Snead OC; Horton EJ
    Pediatr Neurol; 1995 Sep; 13(2):108-10. PubMed ID: 8534274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropic hormone therapy for infantile spasms alters pyruvate metabolism in the central nervous system.
    Miyazaki M; Hashimoto T; Yoneda Y; Saijio T; Mori K; Ito M; Kuroda Y
    Brain Dev; 1998 Aug; 20(5):312-8. PubMed ID: 9761001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
    Pranzatelli MR; Huang YY; Tate E; Goldstein DS; Holmes CS; Goldstein EM; Ketner K; Kinast M; Lange BM; Sanz A; Shevell MI; Stanford RE; Taff IP
    Mov Disord; 1998 May; 13(3):522-8. PubMed ID: 9613746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile spasm: the effect of corticotropin (ACTH) on the free amino acid profile in cerebrospinal fluid.
    Tekgül H; Tütüncüoglu S; Coker M; Coker C
    Brain Dev; 1999 Jan; 21(1):20-3. PubMed ID: 10082248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.